Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Innovative Solutions & Support
IA
$372M
| $349K | ﹤0.01% |
+19,369
| New | +$375K |
2026 Q2
0 quarters
|
|
3327
Zegna
ZGN
$3.63B
| $347K | ﹤0.01% |
26,652
-13,536
| -34% | -$175K |
2022 Q1
17 quarters
|
|
3328
iShares Russell Top 200 Growth ETF
IWY
$15.2B
| $347K | ﹤0.01% |
+1,194
| New | +$337K |
2026 Q2
0 quarters
|
|
3329
National Healthcare Properties, Inc. Common Stock
NHP
$1.1B
| $347K | ﹤0.01% |
+23,677
| New | +$331K |
2026 Q2
0 quarters
|
|
3330
iShares US Financials ETF
IYF
$3.84B
| $346K | ﹤0.01% |
+2,713
| New | +$337K |
2026 Q2
0 quarters
|
|
3331
Park-Ohio Holdings
PKOH
$625M
| $345K | ﹤0.01% |
8,973
-2,130
| -19% | -$65.5K |
2023 Q3
11 quarters
|
|
3332
Chemung Financial Corp
CHMG
$416M
| $344K | ﹤0.01% |
4,609
+157
| +4% | +$10.5K |
2025 Q4
2 quarters
|
|
3333
Virtus Diversified Income & Convertible Fund
ACV
$248M
| $341K | ﹤0.01% |
12,022
-7,509
| -38% | -$202K |
2025 Q1
5 quarters
|
|
3334
Aldeyra Therapeutics
ALDX
$33.8M
| $340K | ﹤0.01% |
159,540
-10,158
| -6% | -$17.5K |
2022 Q3
15 quarters
|
|
3335
DELISTED
Liberty Broadband Class A
LBRDA
| $339K | ﹤0.01% |
10,199
+744
| +8% | +$29K |
2016 Q1
41 quarters
|
|
3336
Timberland Bancorp
TSBK
$364M
| $337K | ﹤0.01% |
7,516
+284
| +4% | +$11.7K |
2025 Q4
2 quarters
|
|
3337
First Bank
FRBA
$481M
| $336K | ﹤0.01% |
18,965
-2,698
| -12% | -$43.3K |
2023 Q4
10 quarters
|
|
3338
Alvotech
ALVO
$1.66B
| $334K | ﹤0.01% |
90,477
+12,030
| +15% | +$43K |
2024 Q4
6 quarters
|
|
3339
McGraw Hill
MH
$2.55B
| $333K | ﹤0.01% |
35,145
+8,418
| +31% | +$101K |
2025 Q3
3 quarters
|
|
3340
Beta Bionics
BBNX
$911M
| $329K | ﹤0.01% |
21,021
+1,557
| +8% | +$18.5K |
2025 Q1
5 quarters
|
|
3341
Western Asset High Yield Opportunity Fund Inc
HYI
$123M
| $328K | ﹤0.01% |
30,896
-25,990
| -46% | -$278K |
2024 Q1
9 quarters
|
|
3342
KRONOS Worldwide
KRO
$863M
| $327K | ﹤0.01% |
51,715
+2,641
| +5% | +$18.1K |
2013 Q2
52 quarters
|
|
3343
MediaAlpha
MAX
$873M
| $327K | ﹤0.01% |
26,039
+2,412
| +10% | +$22.8K |
2025 Q2
4 quarters
|
|
3344
Utah Medical Products
UTMD
$216M
| $327K | ﹤0.01% |
4,738
+621
| +15% | +$41.3K |
2025 Q1
5 quarters
|
|
3345
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.46B
| $327K | ﹤0.01% |
3,374
| – | – |
2026 Q1
1 quarter
|
|
3346
Entrada Therapeutics
TRDA
$177M
| $326K | ﹤0.01% |
44,344
+2,418
| +6% | +$23.2K |
2024 Q4
6 quarters
|
|
3347
ODDITY Tech
ODD
$1000M
| $326K | ﹤0.01% |
+21,563
| New | +$289K |
2026 Q2
0 quarters
|
|
3348
Assembly Biosciences
ASMB
$410M
| $326K | ﹤0.01% |
+11,864
| New | +$323K |
2026 Q2
0 quarters
|
|
3349
Clough Global Equity Fund
GLQ
$141M
| $325K | ﹤0.01% |
37,752
+42
| +0.1% | +$347 |
2024 Q3
7 quarters
|
|
3350
Calamos Convertible and High Income Fund
CHY
$892M
| $325K | ﹤0.01% |
+23,892
| New | +$302K |
2026 Q2
0 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.